Video

Dr. Metz Discusses Using a Multidisciplinary Approach When Treating NETs

David C. Metz, MBBCh, professor of medicine, co-director, GI Physiology laboratory, Hospital of the University of Pennsylvania, discusses using a multidisciplinary approach to treating neuroendocrine tumors (NETs).

David C. Metz, MBBCh, professor of medicine, co-director, GI Physiology laboratory, Hospital of the University of Pennsylvania, discusses using a multidisciplinary approach to treating neuroendocrine tumors (NETs).

As NETs have a tremendous spread of potential involvement across disciplines, there is significant potential to having multidisciplinary input.

Metz says the field is growing and important, however, he stresses that not every person that has a NET needs to go to a center of excellence that has a multidisciplinary approach because it is not practical. It is important to have availability across the country in various locations where there are going to be experts that get together and discuss specific patients, Metz says.

In the future, physicians may be moving towards a situation where a virtual tumor board may be available to discuss specific cases of patients in very isolated areas, Metz says. As NETs are not particularly common, physicians are still learning.

<<<

View more from NANETS 2014

Related Videos
Paolo Caimi, MD
Jennifer Scalici, MD
Steven H. Lin, MD, PhD
Anna Weiss, MD, associate professor, Department of Surgery, Oncology, associate professor, Cancer Center, University of Rochester Medicine
Roy S. Herbst, MD, PhD, Ensign Professor of Medicine (Medical Oncology), professor, pharmacology, deputy director, Yale Cancer Center; chief, Hematology/Medical Oncology, Yale Cancer Center and Smilow Cancer Hospital; assistant dean, Translational Research, Yale School of Medicine
Victor Moreno, MD, PhD
Benjamin P. Levy, MD, with Kristie Kahl and Andrew Svonavec
Binod Dhakal, MD
Jill Corre, PharmD, PhD
Saad Z. Usmani, MD, MBA, FACP, FASCO